Healthcare Sector Stocks
The Healthcare sector has a total of 1067 stocks, with a combined market cap of $8.28 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.21.
Market Cap
8.28T
Revenue
4.52T
Profits
201B
PE Ratio
41.21
Profit Margin
4.44%
Dividend Yield
0.43%
1068 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 821.13B | -0.42% | 2,148,487 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 555.22B | 2.01% | 7,096,207 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 355.43B | 0.22% | 7,448,494 | 61.16B |
| 4 | UNH | UnitedHealth Group Incorporated | 322.02B | 0.29% | 6,312,071 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 303.56B | -1.29% | 2,178,970 | 58.74B |
| 6 | NVS | Novartis AG | 283.14B | 0.11% | 1,686,869 | 56.67B |
| 7 | MRK | Merck & Co., Inc. | 283.10B | 1.53% | 6,823,804 | 65.01B |
| 8 | AMGN | Amgen Inc. | 188.15B | 0.78% | 2,032,476 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 173.44B | -9.20% | 5,355,560 | 45.20B |
| 10 | NVO | Novo Nordisk A/S | 171.51B | -1.61% | 11,523,912 | 48.59B |
| 11 | ISRG | Intuitive Surgical, Inc. | 169.58B | -0.99% | 2,888,717 | 10.58B |
| 12 | GILD | Gilead Sciences, Inc. | 165.88B | 0.56% | 3,870,455 | 29.44B |
| 13 | ABT | Abbott Laboratories | 161.07B | 0.85% | 10,110,151 | 45.13B |
| 14 | PFE | Pfizer Inc. | 151.71B | -0.49% | 38,713,587 | 62.58B |
| 15 | DHR | Danaher Corporation | 126.39B | -2.97% | 10,182,632 | 24.78B |
| 16 | SYK | Stryker Corporation | 126.25B | 0.09% | 1,248,214 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.50B | 0.37% | 6,510,925 | 48.19B |
| 18 | SNY | Sanofi | 115.65B | 1.34% | 5,352,831 | 54.85B |
| 19 | GSK | GSK plc | 111.98B | -0.13% | 3,453,339 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 110.67B | -0.59% | 536,108 | 12.00B |
| 21 | MDT | Medtronic plc | 107.58B | 0.68% | 7,863,949 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 105.98B | 0.57% | 871,090 | 75.60B |
| 23 | MCK | McKesson Corporation | 102.41B | 0.83% | 673,802 | 397.96B |
| 24 | CVS | CVS Health Corporation | 101.07B | 3.18% | 6,710,040 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 97.63B | 1.26% | 31,268,049 | 20.61B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.61B | 2.60% | 928,706 | 14.34B |
| 27 | ELV | Elevance Health, Inc. | 75.20B | 5.51% | 2,778,126 | 200.42B |
| 28 | CI | The Cigna Group | 73.75B | 1.83% | 1,694,306 | 274.90B |
| 29 | MDLN | Medline Inc. | 60.73B | -1.97% | 3,707,088 | 28.43B |
| 30 | COR | Cencora, Inc. | 60.57B | 1.00% | 1,262,723 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 52.84B | 0.30% | 1,821,900 | 28.48B |
| 32 | ARGX | argenx SE | 49.93B | -0.64% | 230,395 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 48.81B | -1.24% | 4,532,283 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 48.17B | 2.08% | 1,428,585 | 244.67B |
| 35 | EW | Edwards Lifesciences Corporation | 45.96B | -2.22% | 6,232,630 | 6.30B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.55B | -3.01% | 629,600 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.09B | -0.51% | 2,846,117 | 21.92B |
| 38 | HLN | Haleon plc | 42.26B | 1.82% | 6,969,623 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.62B | 1.03% | 592,666 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.25B | -0.75% | 1,243,652 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.34B | -0.03% | 3,214,864 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 33.25B | -4.05% | 316,338 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 32.34B | -5.02% | 2,620,366 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 31.89B | -2.09% | 3,290,729 | 20.63B |
| 45 | RMD | ResMed Inc. | 31.84B | -1.14% | 986,924 | 5.40B |
| 46 | INSM | Insmed Incorporated | 31.05B | -0.45% | 1,152,345 | 606.42M |
| 47 | WAT | Waters Corporation | 30.55B | -6.93% | 1,452,358 | 3.17B |
| 48 | RPRX | Royalty Pharma plc | 29.43B | -0.16% | 2,081,167 | 2.38B |
| 49 | NTRA | Natera, Inc. | 28.51B | -3.20% | 1,166,204 | 2.31B |
| 50 | RVMD | Revolution Medicines, Inc. | 28.28B | -4.96% | 3,876,415 | - |
| 51 | BIIB | Biogen Inc. | 27.57B | -1.15% | 816,240 | 9.89B |
| 52 | IQV | IQVIA Holdings Inc. | 26.97B | -8.29% | 2,141,676 | 16.31B |
| 53 | BNTX | BioNTech SE | 26.69B | -2.80% | 716,456 | 3.37B |
| 54 | PHG | Koninklijke Philips N.V. | 26.42B | -2.16% | 1,120,103 | 20.94B |
| 55 | HUM | Humana Inc. | 25.81B | -1.13% | 732,030 | 129.66B |
| 56 | MTD | Mettler-Toledo International Inc. | 25.60B | -3.49% | 149,405 | 4.03B |
| 57 | VEEV | Veeva Systems Inc. | 25.50B | -4.66% | 2,923,147 | 3.20B |
| 58 | UTHR | United Therapeutics Corporation | 25.11B | -0.25% | 285,694 | 3.18B |
| 59 | DXCM | DexCom, Inc. | 24.19B | -1.12% | 2,505,448 | 4.66B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.32B | 12.86% | 2,727,701 | 3.07B |
| 61 | DGX | Quest Diagnostics Incorporated | 22.09B | -2.19% | 1,263,365 | 11.28B |
| 62 | STE | STERIS plc | 21.92B | -0.01% | 432,801 | 5.83B |
| 63 | LH | Labcorp Holdings Inc. | 21.77B | -2.82% | 817,016 | 13.95B |
| 64 | MRNA | Moderna, Inc. | 20.96B | -4.95% | 4,061,927 | 1.94B |
| 65 | CNC | Centene Corporation | 20.21B | 5.55% | 4,035,107 | 176.15B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.14B | -3.46% | 7,595,107 | 13.31M |
| 67 | ILMN | Illumina, Inc. | 19.06B | -3.88% | 1,504,495 | 4.34B |
| 68 | INCY | Incyte Corporation | 19.00B | -1.31% | 904,953 | 5.14B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 17.89B | -0.64% | 1,843,730 | 8.23B |
| 70 | SMMT | Summit Therapeutics Inc. | 17.28B | -9.40% | 4,673,819 | - |
| 71 | VTRS | Viatris Inc. | 17.18B | 1.58% | 9,809,676 | 14.30B |
| 72 | GMAB | Genmab A/S | 16.77B | -2.56% | 1,041,588 | 3.72B |
| 73 | THC | Tenet Healthcare Corporation | 16.50B | -1.51% | 1,016,329 | 21.31B |
| 74 | RGC | Regencell Bioscience Holdings Limited | 14.00B | -3.35% | 79,503 | - |
| 75 | ASND | Ascendis Pharma A/S | 13.91B | -2.57% | 831,994 | 845.52M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 13.89B | -3.72% | 2,396,742 | 502.08M |
| 77 | SNN | Smith & Nephew plc | 13.66B | -2.50% | 1,597,492 | 6.16B |
| 78 | ALGN | Align Technology, Inc. | 13.66B | -2.74% | 1,024,529 | 4.03B |
| 79 | PODD | Insulet Corporation | 13.31B | -0.73% | 711,825 | 2.71B |
| 80 | PEN | Penumbra, Inc. | 13.09B | 0.24% | 692,814 | 1.40B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.09B | -0.75% | 518,724 | 2.86B |
| 82 | GMED | Globus Medical, Inc. | 12.77B | -0.65% | 399,188 | 2.94B |
| 83 | COO | The Cooper Companies, Inc. | 12.67B | -2.94% | 2,576,639 | 4.15B |
| 84 | FMS | Fresenius Medical Care AG | 12.33B | -0.52% | 403,213 | 23.05B |
| 85 | JAZZ | Jazz Pharmaceuticals plc | 12.31B | -1.21% | 1,074,627 | 4.27B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.24B | -0.95% | 1,377,101 | 943.71M |
| 87 | SOLV | Solventum Corporation | 11.96B | -0.22% | 871,417 | 8.33B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | -1.97% | 330,167 | 958.40M |
| 89 | RDY | Dr. Reddy's Laboratories Limited | 11.81B | 5.76% | 7,735,868 | 3.85B |
| 90 | EXEL | Exelixis, Inc. | 11.70B | -1.71% | 2,417,847 | 2.32B |
| 91 | GH | Guardant Health, Inc. | 11.53B | -1.89% | 1,656,267 | 982.02M |
| 92 | MEDP | Medpace Holdings, Inc. | 11.24B | -22.63% | 1,635,547 | 2.68B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.18B | -0.31% | 3,672,078 | 4.72B |
| 94 | ENSG | The Ensign Group, Inc. | 11.06B | 1.68% | 442,326 | 5.06B |
| 95 | UHS | Universal Health Services, Inc. | 11.06B | 0.25% | 518,588 | 17.36B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.42B | 0.65% | 2,593,497 | 1.09B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.38B | -0.31% | 1,495,435 | 3.22B |
| 98 | DVA | DaVita Inc. | 10.22B | 1.71% | 606,120 | 13.64B |
| 99 | EHC | Encompass Health Corporation | 10.13B | -0.30% | 670,216 | 5.94B |
| 100 | RVTY | Revvity, Inc. | 9.74B | -7.56% | 2,689,396 | 2.86B |
| 101 | BTSG | BrightSpring Health Services, Inc. | 9.67B | 0.06% | 2,070,002 | 12.91B |
| 102 | BAX | Baxter International Inc. | 9.50B | 0.55% | 4,827,390 | 11.24B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 9.35B | -1.98% | 418,840 | 638.50M |
| 104 | MASI | Masimo Corporation | 9.33B | 0.10% | 623,828 | 1.53B |
| 105 | TEM | Tempus AI, Inc. | 9.22B | -7.33% | 5,532,562 | 1.27B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 9.18B | -2.28% | 324,599 | 7.46M |
| 107 | MOH | Molina Healthcare, Inc. | 9.10B | 14.18% | 3,356,735 | 43.10B |
| 108 | ABVX | ABIVAX Société Anonyme | 9.09B | -2.58% | 570,219 | 5.37M |
| 109 | HSIC | Henry Schein, Inc. | 8.98B | 0.14% | 838,868 | 13.18B |
| 110 | PCVX | Vaxcyte, Inc. | 8.75B | 0.03% | 929,719 | - |
| 111 | NUVL | Nuvalent, Inc. | 8.49B | -0.76% | 1,030,307 | - |
| 112 | IBRX | ImmunityBio, Inc. | 8.46B | 1.49% | 9,749,133 | 113.29M |
| 113 | CRL | Charles River Laboratories International, Inc. | 8.28B | -9.23% | 1,237,874 | 4.02B |
| 114 | TECH | Bio-Techne Corporation | 8.17B | -10.89% | 3,178,642 | 1.22B |
| 115 | CYTK | Cytokinetics, Incorporated | 8.14B | -1.16% | 1,677,578 | 88.04M |
| 116 | ICLR | ICON Public Limited Company | 8.12B | -7.87% | 2,320,219 | 8.10B |
| 117 | ATR | AptarGroup, Inc. | 7.97B | 0.31% | 335,563 | 3.78B |
| 118 | KRYS | Krystal Biotech, Inc. | 7.89B | -2.86% | 160,340 | 389.13M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.89B | -2.65% | 2,376,647 | 1.40B |
| 120 | QGEN | Qiagen N.V. | 7.85B | -5.00% | 1,895,981 | 2.09B |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 7.60B | -6.44% | 423,539 | 2.58B |
| 122 | KYMR | Kymera Therapeutics, Inc. | 7.12B | -1.80% | 411,168 | 39.21M |
| 123 | GKOS | Glaukos Corporation | 7.07B | -0.64% | 402,242 | 507.44M |
| 124 | ERAS | Erasca, Inc. | 6.98B | 3.79% | 9,454,055 | - |
| 125 | ACLX | Arcellx, Inc. | 6.75B | 0.04% | 1,160,528 | 22.29M |
| 126 | HQY | HealthEquity, Inc. | 6.57B | -6.19% | 1,163,232 | 1.31B |
| 127 | GRFS | Grifols, S.A. | 6.56B | -4.89% | 559,650 | 8.83B |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.55B | -2.78% | 651,592 | 46.02M |
| 129 | APGE | Apogee Therapeutics, Inc. | 6.52B | -2.64% | 400,382 | - |
| 130 | BLTE | Belite Bio, Inc | 6.47B | -1.77% | 66,080 | - |
| 131 | RGEN | Repligen Corporation | 6.43B | -8.31% | 2,174,653 | 738.26M |
| 132 | HIMS | Hims & Hers Health, Inc. | 6.42B | -2.96% | 42,909,414 | 2.35B |
| 133 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.08% | 1,716,217 | 15.00M |
| 134 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | -0.02% | 2,480,433 | - |
| 135 | TFX | Teleflex Incorporated | 6.05B | -1.56% | 1,069,834 | 1.99B |
| 136 | SYRE | Spyre Therapeutics, Inc. | 5.97B | -5.15% | 660,404 | - |
| 137 | CGON | CG Oncology, Inc. | 5.90B | 0.01% | 1,121,947 | 4.04M |
| 138 | IMVT | Immunovant, Inc. | 5.88B | -1.97% | 1,333,118 | - |
| 139 | COGT | Cogent Biosciences, Inc. | 5.82B | -0.69% | 1,123,234 | - |
| 140 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.82B | 0.04% | 510,928 | 189.76M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.68B | -3.19% | 657,409 | 1.73B |
| 142 | ALKS | Alkermes plc | 5.64B | 0.50% | 1,109,307 | 1.48B |
| 143 | BLCO | Bausch + Lomb Corporation | 5.62B | -1.68% | 560,861 | 5.10B |
| 144 | CAI | Caris Life Sciences, Inc. | 5.59B | -3.46% | 1,540,777 | 812.03M |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 5.55B | -2.50% | 317,587 | 521.31M |
| 146 | BRKR | Bruker Corporation | 5.51B | -8.70% | 3,159,505 | 3.44B |
| 147 | PACS | PACS Group, Inc. | 5.51B | 0.14% | 440,464 | 5.29B |
| 148 | CELC | Celcuity Inc. | 5.49B | -7.24% | 792,020 | - |
| 149 | SRRK | Scholar Rock Holding Corporation | 5.45B | 0.32% | 1,026,089 | - |
| 150 | TGTX | TG Therapeutics, Inc. | 5.45B | -3.63% | 1,806,905 | 616.29M |
| 151 | LNTH | Lantheus Holdings, Inc. | 5.38B | -0.07% | 316,272 | 1.54B |
| 152 | CRSP | CRISPR Therapeutics AG | 5.31B | -2.20% | 1,390,204 | 3.51M |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | -2.19% | 581,807 | 7.50M |
| 154 | AVTR | Avantor, Inc. | 5.25B | -6.28% | 11,275,924 | 6.55B |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.12% | 2,769,554 | 1.00B |
| 156 | CHE | Chemed Corporation | 5.14B | 2.63% | 258,690 | 2.54B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.89B | -1.61% | 356,304 | 2.04M |
| 158 | OSCR | Oscar Health, Inc. | 4.89B | -0.06% | 4,001,248 | 11.70B |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.84B | -3.20% | 881,297 | 761.41M |
| 160 | WAY | Waystar Holding Corp. | 4.77B | -2.01% | 1,456,337 | 1.10B |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 4.56B | 0.71% | 172,379 | 268.09M |
| 162 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 1,823,367 | 634.21M |
| 163 | OPCH | Option Care Health, Inc. | 4.48B | 0.56% | 1,018,979 | 5.65B |
| 164 | LEGN | Legend Biotech Corporation | 4.44B | -7.48% | 2,313,806 | 1.03B |
| 165 | STVN | Stevanato Group S.p.A. | 4.43B | 4.37% | 767,746 | 1.39B |
| 166 | RDNT | RadNet, Inc. | 4.42B | -2.40% | 497,028 | 2.04B |
| 167 | NVST | Envista Holdings Corporation | 4.41B | -0.37% | 1,630,997 | 2.72B |
| 168 | SHC | Sotera Health Company | 4.37B | -1.92% | 1,977,583 | 1.16B |
| 169 | DOCS | Doximity, Inc. | 4.28B | -4.49% | 1,986,187 | 637.78M |
| 170 | ALHC | Alignment Healthcare, Inc. | 4.26B | -0.86% | 2,041,045 | 3.95B |
| 171 | MMSI | Merit Medical Systems, Inc. | 4.09B | -1.59% | 535,011 | 1.52B |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 4.04B | -1.33% | 1,883,292 | 3.02B |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.03B | -1.51% | 658,354 | 7.70M |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.96B | -0.40% | 220,650 | 747.14M |
| 175 | TMDX | TransMedics Group, Inc. | 3.91B | -1.26% | 842,562 | 605.49M |
| 176 | BLLN | BillionToOne, Inc. | 3.86B | -3.35% | 353,071 | 305.11M |
| 177 | MMED | MiniMed Group, Inc. | 3.83B | 3.34% | 894,133 | 2.99B |
| 178 | VKTX | Viking Therapeutics, Inc. | 3.80B | -4.23% | 2,453,355 | - |
| 179 | TVTX | Travere Therapeutics, Inc. | 3.77B | 1.82% | 1,764,402 | 490.73M |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -0.58% | 1,209,367 | 1.07B |
| 181 | TNGX | Tango Therapeutics, Inc. | 3.73B | -3.97% | 2,824,285 | 62.38M |
| 182 | NAMS | NewAmsterdam Pharma Company N.V. | 3.62B | -1.50% | 520,378 | 22.50M |
| 183 | TWST | Twist Bioscience Corporation | 3.61B | -6.88% | 1,672,866 | 391.56M |
| 184 | LIVN | LivaNova PLC | 3.57B | 0.05% | 381,996 | 1.39B |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.50B | -1.36% | 123,767 | 803.79M |
| 186 | ORKA | Oruka Therapeutics, Inc. | 3.40B | -2.78% | 1,681,137 | - |
| 187 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.38B | 6.71% | 2,966,960 | 588.99M |
| 188 | EWTX | Edgewise Therapeutics, Inc. | 3.35B | -2.92% | 877,699 | - |
| 189 | HNGE | Hinge Health, Inc. | 3.35B | -3.40% | 517,916 | 587.86M |
| 190 | GPCR | Structure Therapeutics Inc. | 3.33B | 1.12% | 795,754 | - |
| 191 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.31B | -0.01% | 567,623 | 677.56M |
| 192 | ALMS | Alumis Inc. | 3.31B | 0.39% | 1,674,247 | 24.05M |
| 193 | LQDA | Liquidia Corporation | 3.30B | 1.08% | 609,741 | 158.32M |
| 194 | BKD | Brookdale Senior Living Inc. | 3.24B | 1.64% | 1,742,933 | 3.05B |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.15B | -5.60% | 1,371,702 | 247.00M |
| 196 | DYN | Dyne Therapeutics, Inc. | 3.12B | -3.91% | 1,794,803 | - |
| 197 | ICUI | ICU Medical, Inc. | 3.12B | -2.04% | 214,761 | 2.23B |
| 198 | KLRA | Kailera Therapeutics, Inc. | 3.10B | 3.21% | 3,995,778 | - |
| 199 | DNLI | Denali Therapeutics Inc. | 3.08B | -3.95% | 1,221,096 | - |
| 200 | NKTR | Nektar Therapeutics | 3.03B | -2.08% | 1,843,165 | 55.23M |
| 201 | BEAM | Beam Therapeutics Inc. | 3.02B | -4.83% | 2,694,317 | 139.74M |
| 202 | CON | Concentra Group Holdings Parent, Inc. | 2.96B | 1.59% | 708,724 | 2.16B |
| 203 | PRVA | Privia Health Group, Inc. | 2.95B | -1.51% | 710,342 | 2.12B |
| 204 | SUPN | Supernus Pharmaceuticals, Inc. | 2.90B | 0.20% | 287,029 | 718.95M |
| 205 | ITGR | Integer Holdings Corporation | 2.89B | -0.35% | 699,324 | 1.85B |
| 206 | RLAY | Relay Therapeutics, Inc. | 2.86B | -8.60% | 2,972,042 | 15.36M |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 2.84B | -3.75% | 1,060,988 | 376.07M |
| 208 | KOD | Kodiak Sciences Inc. | 2.79B | 0.04% | 635,782 | - |
| 209 | HAE | Haemonetics Corporation | 2.77B | -2.47% | 1,554,424 | 1.32B |
| 210 | VERA | Vera Therapeutics, Inc. | 2.75B | -4.67% | 823,331 | - |
| 211 | WRBY | Warby Parker Inc. | 2.75B | -8.62% | 1,869,782 | 871.91M |
| 212 | TXG | 10x Genomics, Inc. | 2.74B | -6.18% | 3,384,986 | 642.82M |
| 213 | PBH | Prestige Consumer Healthcare Inc. | 2.73B | 0.98% | 710,538 | 1.10B |
| 214 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.15% | 1,426,993 | 190.41M |
| 215 | LFST | LifeStance Health Group, Inc. | 2.72B | 1.16% | 1,220,463 | 1.42B |
| 216 | IDYA | IDEAYA Biosciences, Inc. | 2.70B | -3.06% | 1,311,281 | 218.71M |
| 217 | HTFL | HeartFlow, Inc. | 2.68B | -5.13% | 713,823 | 176.03M |
| 218 | NHC | National HealthCare Corporation | 2.66B | -1.76% | 180,105 | 1.52B |
| 219 | VCYT | Veracyte, Inc. | 2.63B | -1.66% | 807,532 | 517.15M |
| 220 | CLDX | Celldex Therapeutics, Inc. | 2.63B | -1.93% | 728,831 | 1.55M |
| 221 | ELVN | Enliven Therapeutics, Inc. | 2.62B | -1.24% | 473,141 | - |
| 222 | IRON | Disc Medicine, Inc. | 2.61B | -1.99% | 294,193 | - |
| 223 | IMNM | Immunome, Inc. | 2.60B | -3.32% | 559,355 | 6.94M |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.59B | -3.95% | 798,972 | 451.36M |
| 225 | MANE | Veradermics, Incorporated | 2.59B | -1.51% | 236,231 | - |
| 226 | LMAT | LeMaitre Vascular, Inc. | 2.58B | 0.09% | 121,608 | 249.60M |
| 227 | ADMA | ADMA Biologics, Inc. | 2.57B | 1.19% | 5,659,325 | 510.17M |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.52B | -2.39% | 1,982,378 | 3.31B |
| 229 | ZLAB | Zai Lab Limited | 2.46B | -4.33% | 707,172 | 460.16M |
| 230 | RARE | Ultragenyx Pharmaceutical Inc. | 2.38B | -1.34% | 1,464,374 | 673.00M |
| 231 | XRAY | DENTSPLY SIRONA Inc. | 2.37B | -2.22% | 1,713,691 | 3.68B |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | -1.52% | 762,496 | - |
| 233 | GRDN | Guardian Pharmacy Services, Inc. | 2.34B | 1.96% | 266,025 | 1.45B |
| 234 | HCM | HUTCHMED (China) Limited | 2.33B | -4.53% | 34,410 | 548.51M |
| 235 | DFTX | Definium Therapeutics, Inc. | 2.32B | 0.78% | 1,846,618 | - |
| 236 | OGN | Organon & Co. | 2.24B | -5.91% | 4,265,592 | 6.22B |
| 237 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | - | 158.18M |
| 238 | PAHC | Phibro Animal Health Corporation | 2.22B | 1.33% | 158,652 | 1.46B |
| 239 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.20B | -2.77% | 2,464,756 | 874.84M |
| 240 | TYRA | Tyra Biosciences, Inc. | 2.18B | -1.77% | 692,844 | - |
| 241 | AAPG | Ascentage Pharma Group International | 2.15B | -11.10% | 9,408 | 82.08M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | -1.71% | 890,020 | 283.06M |
| 243 | SRPT | Sarepta Therapeutics, Inc. | 2.14B | -1.07% | 4,489,191 | 2.20B |
| 244 | ADPT | Adaptive Biotechnologies Corporation | 2.13B | -2.68% | 1,005,839 | 276.98M |
| 245 | OCUL | Ocular Therapeutix, Inc. | 2.09B | -0.72% | 2,518,664 | 51.95M |
| 246 | GRAL | GRAIL, Inc. | 2.08B | -3.71% | 474,280 | 147.17M |
| 247 | BHC | Bausch Health Companies Inc. | 2.07B | -2.46% | 1,437,123 | 10.27B |
| 248 | STOK | Stoke Therapeutics, Inc. | 2.07B | -2.70% | 344,154 | 184.42M |
| 249 | SEM | Select Medical Holdings Corporation | 2.04B | - | 453,556 | 5.45B |
| 250 | NEOG | Neogen Corporation | 2.04B | -1.79% | 4,302,890 | 870.56M |
| 251 | MESO | Mesoblast Limited | 2.02B | -1.52% | 292,037 | 65.38M |
| 252 | ZYME | Zymeworks Inc. | 2.02B | -3.86% | 463,577 | 105.97M |
| 253 | TRVI | Trevi Therapeutics, Inc. | 1.99B | -4.12% | 1,737,404 | - |
| 254 | CAPR | Capricor Therapeutics, Inc. | 1.96B | -3.26% | 845,157 | 11.13M |
| 255 | AXGN | Axogen, Inc. | 1.94B | 1.11% | 924,121 | 225.21M |
| 256 | WGS | GeneDx Holdings Corp. | 1.94B | -5.14% | 544,305 | 427.54M |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.91B | -1.14% | 498,384 | -665.00K |
| 258 | ESTA | Establishment Labs Holdings Inc. | 1.91B | -2.94% | 294,919 | 211.08M |
| 259 | GLPG | Galapagos NV | 1.91B | -1.58% | 98,267 | 1.31B |
| 260 | SGRY | Surgery Partners, Inc. | 1.88B | -0.68% | 1,101,873 | 3.31B |
| 261 | NTLA | Intellia Therapeutics, Inc. | 1.87B | -4.22% | 5,486,970 | 67.67M |
| 262 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | 0.34% | 1,303,248 | 868.45M |
| 263 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -4.89% | 2,488,118 | 172.35M |
| 264 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | -6.17% | 10,288,579 | 74.68M |
| 265 | MD | Pediatrix Medical Group, Inc. | 1.85B | -0.39% | 275,217 | 1.91B |
| 266 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | -4.76% | 2,153,085 | 9.77M |
| 267 | PVLA | Palvella Therapeutics, Inc. | 1.82B | -2.75% | 149,124 | - |
| 268 | AORT | Artivion, Inc. | 1.80B | 0.35% | 164,556 | 441.33M |
| 269 | PHVS | Pharvaris N.V. | 1.78B | -9.15% | 253,467 | - |
| 270 | ANIP | ANI Pharmaceuticals, Inc. | 1.78B | -2.60% | 206,474 | 883.37M |
| 271 | NUVB | Nuvation Bio Inc. | 1.75B | -1.56% | 2,151,668 | 62.90M |
| 272 | VCEL | Vericel Corporation | 1.75B | 0.09% | 446,972 | 276.26M |
| 273 | INBX | Inhibrx Biosciences, Inc. | 1.75B | 4.21% | 955,759 | 1.30M |
| 274 | ATAI | AtaiBeckley Inc. | 1.74B | 1.27% | 8,475,427 | 4.09M |
| 275 | INVA | Innoviva, Inc. | 1.74B | -0.09% | 387,158 | 411.33M |
| 276 | RAPP | Rapport Therapeutics, Inc. | 1.74B | -1.14% | 314,759 | - |
| 277 | AHCO | AdaptHealth Corp. | 1.73B | 0.16% | 1,146,000 | 3.24B |
| 278 | SION | Sionna Therapeutics, Inc. | 1.73B | -11.23% | 449,480 | - |
| 279 | NRIX | Nurix Therapeutics, Inc. | 1.71B | -0.36% | 921,483 | 71.78M |
| 280 | AHG | Akso Health Group | 1.71B | 1.01% | 183,879 | 14.84M |
| 281 | ADUS | Addus HomeCare Corporation | 1.71B | -0.33% | 315,403 | 1.42B |
| 282 | VIR | Vir Biotechnology, Inc. | 1.67B | -3.00% | 1,206,773 | 68.56M |
| 283 | ALMR | Alamar Biosciences, Inc. | 1.66B | - | 186,837 | 74.21M |
| 284 | OMCL | Omnicell, Inc. | 1.65B | -0.76% | 293,693 | 1.18B |
| 285 | PLSE | Pulse Biosciences, Inc. | 1.65B | -0.74% | 215,975 | 350.00K |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.64B | 3.14% | 518,691 | 336.39M |
| 287 | GENB | Generate Biomedicines, Inc. | 1.64B | -1.30% | 283,992 | 31.89M |
| 288 | NBTX | Nanobiotix S.A. | 1.63B | 4.71% | 84,688 | 38.27M |
| 289 | ASTH | Astrana Health, Inc. | 1.63B | -2.28% | 428,578 | 3.18B |
| 290 | INSP | Inspire Medical Systems, Inc. | 1.62B | 3.97% | 1,191,310 | 911.98M |
| 291 | GLUE | Monte Rosa Therapeutics, Inc. | 1.61B | -3.86% | 853,598 | 123.67M |
| 292 | PRGO | Perrigo Company plc | 1.61B | -1.10% | 2,111,040 | 4.25B |
| 293 | MBX | MBX Biosciences, Inc. | 1.59B | -0.57% | 557,295 | - |
| 294 | OCS | Oculis Holding AG | 1.58B | -3.88% | 415,792 | 1.51M |
| 295 | BHVN | Biohaven Ltd. | 1.58B | -1.50% | 1,237,078 | - |
| 296 | ATEC | Alphatec Holdings, Inc. | 1.55B | -3.86% | 1,989,285 | 764.16M |
| 297 | DMRA | Damora Therapeutics, Inc. | 1.53B | -1.85% | 99,615 | - |
| 298 | UFPT | UFP Technologies, Inc. | 1.53B | -2.77% | 192,323 | 602.80M |
| 299 | AGIO | Agios Pharmaceuticals, Inc. | 1.51B | -3.67% | 1,020,333 | 54.03M |
| 300 | BCAX | Bicara Therapeutics Inc. | 1.50B | -3.34% | 467,041 | - |
| 301 | IMTX | Immatics N.V. | 1.50B | -0.98% | 364,941 | 56.67M |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.49B | -5.81% | 1,607,196 | 1.85B |
| 303 | IMCR | Immunocore Holdings plc | 1.49B | -2.50% | 296,933 | 400.02M |
| 304 | ANAB | AnaptysBio, Inc. | 1.47B | -4.26% | 409,348 | 234.60M |
| 305 | VRDN | Viridian Therapeutics, Inc. | 1.47B | -0.70% | 1,225,390 | 70.85M |
| 306 | ARDX | Ardelyx, Inc. | 1.46B | -1.00% | 2,031,873 | 407.32M |
| 307 | NVCR | NovoCure Limited | 1.46B | -3.30% | 953,721 | 655.35M |
| 308 | HROW | Harrow, Inc. | 1.44B | -1.00% | 490,249 | 272.30M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.44B | -1.85% | 583,613 | 2.50M |
| 310 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | -1.42% | 14,659,828 | 263.50M |
| 311 | ATRC | AtriCure, Inc. | 1.43B | 2.10% | 646,897 | 534.53M |
| 312 | TNDM | Tandem Diabetes Care, Inc. | 1.42B | -0.48% | 2,158,608 | 1.01B |
| 313 | AVAH | Aveanna Healthcare Holdings Inc. | 1.42B | 0.62% | 901,470 | 2.43B |
| 314 | WVE | Wave Life Sciences Ltd. | 1.41B | -0.95% | 2,464,824 | 42.73M |
| 315 | PGEN | Precigen, Inc. | 1.40B | - | 5,196,032 | 9.68M |
| 316 | ARDT | Ardent Health, Inc. | 1.39B | -1.73% | 348,710 | 6.32B |
| 317 | PGNY | Progyny, Inc. | 1.38B | -1.78% | 817,890 | 1.29B |
| 318 | AVBP | ArriVent BioPharma, Inc. | 1.37B | 0.34% | 455,805 | - |
| 319 | PRCT | PROCEPT BioRobotics Corporation | 1.37B | -3.46% | 1,511,887 | 308.05M |
| 320 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | -10.25% | 2,326,648 | - |
| 321 | OLMA | Olema Pharmaceuticals, Inc. | 1.34B | -5.48% | 723,183 | - |
| 322 | NVAX | Novavax, Inc. | 1.33B | -3.55% | 3,378,250 | 1.12B |
| 323 | KMTS | Kestra Medical Technologies, Ltd. | 1.33B | -4.58% | 153,341 | 83.72M |
| 324 | ENOV | Enovis Corporation | 1.31B | -4.00% | 1,409,452 | 2.25B |
| 325 | BFLY | Butterfly Network, Inc. | 1.31B | -6.87% | 6,607,362 | 97.61M |
| 326 | MPLT | MapLight Therapeutics, Inc. | 1.28B | -9.40% | 561,908 | - |
| 327 | CLOV | Clover Health Investments, Corp. | 1.26B | -4.00% | 6,264,805 | 1.92B |
| 328 | SVRA | Savara Inc. | 1.25B | -3.89% | 1,766,687 | - |
| 329 | JBIO | Jade Biosciences, Inc. | 1.24B | -0.67% | 683,872 | - |
| 330 | CMPS | COMPASS Pathways plc | 1.23B | 4.57% | 4,689,130 | - |
| 331 | STAA | STAAR Surgical Company | 1.23B | 0.16% | 1,195,289 | 239.44M |
| 332 | ABCL | AbCellera Biologics Inc. | 1.23B | -0.74% | 8,001,630 | 75.13M |
| 333 | AKTS | Aktis Oncology, Inc. | 1.22B | 0.36% | 270,524 | 6.50M |
| 334 | MLTX | MoonLake Immunotherapeutics | 1.21B | -1.68% | 639,971 | - |
| 335 | PHAR | Pharming Group N.V. | 1.20B | -2.58% | 5,045 | 376.13M |
| 336 | NNNN | Anbio Biotechnology | 1.20B | -4.08% | 10,791 | 8.65M |
| 337 | URGN | UroGen Pharma Ltd. | 1.18B | -6.72% | 895,669 | 109.79M |
| 338 | GHRS | GH Research PLC | 1.17B | -0.74% | 293,996 | - |
| 339 | DBVT | DBV Technologies S.A. | 1.16B | -1.37% | 163,699 | 5.64M |
| 340 | AZTA | Azenta, Inc. | 1.16B | -5.10% | 964,126 | 595.03M |
| 341 | EYPT | EyePoint, Inc. | 1.15B | -2.81% | 685,291 | 31.37M |
| 342 | AVNS | Avanos Medical, Inc. | 1.15B | 0.24% | 1,404,885 | 701.20M |
| 343 | IRMD | IRADIMED CORPORATION | 1.14B | -1.49% | 53,091 | 83.81M |
| 344 | USPH | U.S. Physical Therapy, Inc. | 1.13B | -1.01% | 128,549 | 773.34M |
| 345 | CNMD | CONMED Corporation | 1.13B | -2.57% | 354,538 | 1.37B |
| 346 | EVO | Evotec SE | 1.12B | -2.12% | 754,104 | 925.65M |
| 347 | SEPN | Septerna, Inc. | 1.12B | -3.44% | 347,311 | 45.95M |
| 348 | QURE | uniQure N.V. | 1.11B | -1.35% | 725,799 | 16.10M |
| 349 | ZBIO | Zenas BioPharma, Inc. | 1.10B | -7.87% | 522,523 | 10.00M |
| 350 | IVA | Inventiva S.A. | 1.09B | -0.76% | 161,148 | 7.94M |
| 351 | CRON | Cronos Group Inc. | 1.07B | -7.14% | 5,168,209 | 146.59M |
| 352 | ALVO | Alvotech | 1.06B | -3.43% | 443,894 | 588.90M |
| 353 | PNTG | The Pennant Group, Inc. | 1.05B | 2.35% | 158,053 | 947.71M |
| 354 | INNV | InnovAge Holding Corp. | 1.05B | 1.18% | 133,598 | 915.37M |
| 355 | BLFS | BioLife Solutions, Inc. | 1.05B | -4.74% | 483,569 | 96.21M |
| 356 | ORIC | ORIC Pharmaceuticals, Inc. | 1.05B | -3.16% | 1,091,195 | - |
| 357 | COLL | Collegium Pharmaceutical, Inc. | 1.05B | -2.36% | 348,241 | 780.57M |
| 358 | NEO | NeoGenomics, Inc. | 1.03B | -3.18% | 1,987,437 | 727.33M |
| 359 | TDOC | Teladoc Health, Inc. | 1.03B | -3.72% | 3,847,054 | 2.53B |
| 360 | CDNA | CareDx, Inc. | 1.03B | -2.76% | 453,140 | 379.81M |
| 361 | PCRX | Pacira BioSciences, Inc. | 1.03B | 1.93% | 646,612 | 726.41M |
| 362 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -1.49% | 1,070,927 | 291.85M |
| 363 | ANNX | Annexon, Inc. | 984.79M | -3.19% | 2,087,244 | - |
| 364 | KALV | KalVista Pharmaceuticals, Inc. | 977.33M | -2.45% | 1,674,461 | 73.62M |
| 365 | OMER | Omeros Corporation | 973.39M | 1.12% | 785,705 | - |
| 366 | PHAT | Phathom Pharmaceuticals, Inc. | 965.87M | 3.67% | 1,251,538 | 175.11M |
| 367 | CTMX | CytomX Therapeutics, Inc. | 961.99M | -3.47% | 1,698,929 | 76.20M |
| 368 | GERN | Geron Corporation | 961.35M | -3.23% | 8,988,012 | 183.88M |
| 369 | SANA | Sana Biotechnology, Inc. | 943.85M | -6.78% | 2,882,919 | - |
| 370 | CMPX | Compass Therapeutics, Inc. | 938.26M | -2.07% | 1,079,610 | 850.00K |
| 371 | AMPH | Amphastar Pharmaceuticals, Inc. | 935.68M | 0.10% | 302,316 | 719.89M |
| 372 | EVMN | Evommune, Inc. | 930.71M | -4.72% | 180,554 | 13.00M |
| 373 | OPK | OPKO Health, Inc. | 926.06M | -0.81% | 1,415,084 | 606.88M |
| 374 | JANX | Janux Therapeutics, Inc. | 924.03M | -1.30% | 572,154 | 10.00M |
| 375 | CERT | Certara, Inc. | 919.95M | -5.96% | 3,326,142 | 418.84M |
| 376 | XNCR | Xencor, Inc. | 913.07M | -3.11% | 317,203 | 125.58M |
| 377 | INMD | InMode Ltd. | 909.83M | -0.35% | 453,238 | 370.50M |
| 378 | LMRI | Lumexa Imaging Holdings, Inc. | 904.39M | 0.86% | 451,400 | 1.02B |
| 379 | ANRO | Alto Neuroscience, Inc. | 901.21M | -5.34% | 230,069 | - |
| 380 | FTRE | Fortrea Holdings Inc. | 900.41M | -8.29% | 1,754,727 | 2.72B |
| 381 | MRVI | Maravai LifeSciences Holdings, Inc. | 886.88M | -6.50% | 1,794,471 | 185.74M |
| 382 | LBRX | LB Pharmaceuticals Inc | 882.47M | -3.16% | 172,718 | - |
| 383 | SSII | SS Innovations International, Inc. | 879.76M | -4.35% | 38,960 | 42.48M |
| 384 | DRUG | Bright Minds Biosciences Inc. | 875.40M | -1.63% | 191,619 | - |
| 385 | TALK | Talkspace, Inc. | 863.78M | -0.39% | 1,313,584 | 228.87M |
| 386 | MGTX | MeiraGTx Holdings plc | 862.63M | -7.08% | 1,033,360 | 81.39M |
| 387 | CBIO | Crescent Biopharma, Inc. | 853.60M | -4.74% | 417,336 | 10.84M |
| 388 | SDGR | Schrödinger, Inc. | 842.34M | -7.61% | 1,808,445 | 255.87M |
| 389 | TBPH | Theravance Biopharma, Inc. | 839.85M | -1.57% | 284,282 | 107.46M |
| 390 | OMDA | Omada Health, Inc. | 837.92M | -2.67% | 1,279,964 | 260.21M |
| 391 | ABUS | Arbutus Biopharma Corporation | 836.99M | -4.06% | 4,998,672 | 14.08M |
| 392 | MNKD | MannKind Corporation | 836.84M | -1.09% | 2,564,469 | 348.97M |
| 393 | SLS | SELLAS Life Sciences Group, Inc. | 833.26M | -2.93% | 4,376,287 | - |
| 394 | SPRY | ARS Pharmaceuticals, Inc. | 824.17M | -1.19% | 2,520,911 | 84.28M |
| 395 | KURA | Kura Oncology, Inc. | 822.83M | -2.73% | 992,947 | 67.48M |
| 396 | SLDB | Solid Biosciences Inc. | 808.80M | -2.14% | 531,389 | - |
| 397 | ALLO | Allogene Therapeutics, Inc. | 808.35M | -1.67% | 8,483,783 | 22.00K |
| 398 | BVS | Bioventus Inc. | 807.43M | -0.61% | 418,293 | 568.09M |
| 399 | TLRY | Tilray Brands, Inc. | 806.62M | -11.82% | 41,705,718 | 858.28M |
| 400 | IART | Integra LifeSciences Holdings Corporation | 804.31M | -4.00% | 645,963 | 1.64B |
| 401 | CBLL | CeriBell, Inc. | 792.54M | -1.29% | 174,411 | 89.06M |
| 402 | VOR | Vor Biopharma Inc. | 792.19M | -4.57% | 940,642 | - |
| 403 | SGP | SpyGlass Pharma, Inc. | 789.87M | -3.51% | 87,634 | - |
| 404 | DSGN | Design Therapeutics, Inc. | 788.17M | -4.41% | 548,590 | - |
| 405 | GDRX | GoodRx Holdings, Inc. | 787.92M | -2.95% | 1,237,311 | 796.85M |
| 406 | AMN | AMN Healthcare Services, Inc. | 784.34M | -2.97% | 340,580 | 2.73B |
| 407 | CGEM | Cullinan Therapeutics, Inc. | 783.81M | -6.43% | 535,901 | - |
| 408 | QDEL | QuidelOrtho Corporation | 765.24M | -5.55% | 1,927,037 | 2.73B |
| 409 | BIOA | BioAge Labs, Inc. | 765.11M | -6.10% | 369,058 | 9.00M |
| 410 | NUTX | Nutex Health Inc. | 761.64M | 0.84% | 172,447 | 875.26M |
| 411 | RLMD | Relmada Therapeutics, Inc. | 760.44M | 2.69% | 689,149 | - |
| 412 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 717.89M | 1.13% | 395,002 | - |
| 413 | CSTL | Castle Biosciences, Inc. | 717.71M | -5.62% | 259,204 | 344.23M |
| 414 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | -7.69% | 2,119,315 | 49.80M |
| 415 | FBRX | Forte Biosciences, Inc. | 706.44M | -3.25% | 242,460 | - |
| 416 | TENX | Tenax Therapeutics, Inc. | 702.70M | 0.36% | 269,720 | - |
| 417 | DRTS | Alpha Tau Medical Ltd. | 702.32M | -1.24% | 365,703 | - |
| 418 | EHAB | Enhabit, Inc. | 696.94M | 0.07% | 753,261 | 1.06B |
| 419 | PRME | Prime Medicine, Inc. | 679.99M | -3.03% | 1,676,235 | 4.63M |
| 420 | GYRE | Gyre Therapeutics, Inc. | 679.38M | -3.75% | 45,638 | 116.59M |
| 421 | ARVN | Arvinas, Inc. | 666.47M | -1.98% | 557,715 | 262.60M |
| 422 | TRAX | First Tracks Biotherapeutics, Inc. | 660.23M | 0.69% | 507,875 | - |
| 423 | BWAY | BrainsWay Ltd. | 646.65M | -0.63% | 79,568 | 52.23M |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 632.43M | 3.64% | 1,993,285 | 7.83M |
| 425 | ETON | Eton Pharmaceuticals, Inc. | 626.72M | -2.71% | 231,718 | 79.95M |
| 426 | IRWD | Ironwood Pharmaceuticals, Inc. | 617.99M | -9.33% | 1,669,100 | 296.15M |
| 427 | PSNL | Personalis, Inc. | 617.60M | -6.50% | 2,279,778 | 69.65M |
| 428 | HSTM | HealthStream, Inc. | 613.07M | -2.65% | 159,295 | 304.06M |
| 429 | ABSI | Absci Corporation | 607.49M | 7.88% | 3,707,908 | 2.80M |
| 430 | PROK | ProKidney Corp. | 603.92M | -4.31% | 496,804 | 893.00K |
| 431 | ANL | Adlai Nortye Ltd. | 596.40M | -7.56% | 427,702 | 5.00M |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 593.57M | -3.62% | 615,689 | 106.47M |
| 433 | SIBN | SI-BONE, Inc. | 591.81M | -3.39% | 399,886 | 200.93M |
| 434 | EIKN | Eikon Therapeutics, Inc. | 579.28M | -7.76% | 133,694 | - |
| 435 | STTK | Shattuck Labs, Inc. | 578.20M | -1.29% | 300,568 | 1.00M |
| 436 | PRTA | Prothena Corporation plc | 577.63M | 0.09% | 474,658 | 9.68M |
| 437 | STRO | Sutro Biopharma, Inc. | 577.04M | -1.97% | 274,327 | 102.48M |
| 438 | CRMD | CorMedix Inc. | 574.88M | -2.14% | 755,061 | 311.71M |
| 439 | NPCE | NeuroPace, Inc. | 567.96M | -0.65% | 259,551 | 99.99M |
| 440 | RIGL | Rigel Pharmaceuticals, Inc. | 567.31M | 0.79% | 178,640 | 294.28M |
| 441 | OCGN | Ocugen, Inc. | 565.32M | -0.60% | 5,254,986 | 4.41M |
| 442 | TCMD | Tactile Systems Technology, Inc. | 556.25M | -2.04% | 174,124 | 329.52M |
| 443 | LYEL | Lyell Immunopharma, Inc. | 552.18M | -4.48% | 80,585 | 36.00K |
| 444 | CTKB | Cytek Biosciences, Inc. | 547.62M | -8.39% | 643,297 | 201.49M |
| 445 | VSTM | Verastem, Inc. | 547.26M | 2.64% | 2,359,514 | 30.91M |
| 446 | ENGN | enGene Therapeutics Inc. | 545.29M | -4.68% | 449,996 | - |
| 447 | EMBC | Embecta Corp. | 543.05M | -0.43% | 560,922 | 1.08B |
| 448 | KYTX | Kyverna Therapeutics, Inc. | 541.75M | -12.51% | 2,196,678 | - |
| 449 | IMMX | Immix Biopharma, Inc. | 539.13M | -0.10% | 385,492 | - |
| 450 | FULC | Fulcrum Therapeutics, Inc. | 538.13M | 4.26% | 718,461 | 80.00M |
| 451 | PHR | Phreesia, Inc. | 537.75M | -5.04% | 1,172,763 | 480.59M |
| 452 | TECX | Tectonic Therapeutic, Inc. | 534.01M | -0.21% | 304,390 | - |
| 453 | CGC | Canopy Growth Corporation | 526.86M | -11.59% | 58,247,614 | 203.04M |
| 454 | AVR | Anteris Technologies Global Corp. | 526.64M | -2.81% | 412,141 | 1.91M |
| 455 | ZURA | Zura Bio Limited | 523.74M | -2.99% | 483,954 | - |
| 456 | UPB | Upstream Bio, Inc. | 521.89M | -0.52% | 416,092 | 2.85M |
| 457 | AGMB | AgomAb Therapeutics NV | 521.48M | 1.42% | 84,714 | - |
| 458 | CADL | Candel Therapeutics, Inc. | 515.66M | -4.09% | 2,260,349 | - |
| 459 | CATX | Perspective Therapeutics, Inc. | 514.22M | -4.25% | 2,392,308 | 884.00K |
| 460 | VREX | Varex Imaging Corporation | 513.93M | 0.99% | 221,558 | 854.40M |
| 461 | BBNX | Beta Bionics, Inc. | 509.34M | -6.31% | 1,279,041 | 110.24M |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 463 | ADCT | ADC Therapeutics SA | 503.67M | -3.18% | 548,215 | 81.36M |
| 464 | MDXG | MiMedx Group, Inc. | 497.70M | 1.21% | 1,577,404 | 418.63M |
| 465 | AQST | Aquestive Therapeutics, Inc. | 496.72M | -1.93% | 1,059,842 | 44.55M |
| 466 | ARMP | Armata Pharmaceuticals, Inc. | 495.64M | -2.73% | 29,640 | 4.90M |
| 467 | ESPR | Esperion Therapeutics, Inc. | 491.64M | -3.05% | 4,400,820 | 403.14M |
| 468 | FDMT | 4D Molecular Therapeutics, Inc. | 490.60M | -1.94% | 535,217 | 85.21M |
| 469 | OFIX | Orthofix Medical Inc. | 487.75M | 0.08% | 154,294 | 822.31M |
| 470 | VALN | Valneva SE | 487.45M | 1.52% | 299,048 | 205.07M |
| 471 | KMDA | Kamada Ltd. | 477.40M | -1.08% | 115,611 | 180.46M |
| 472 | PACB | Pacific Biosciences of California, Inc. | 474.14M | -8.19% | 9,683,036 | 160.01M |
| 473 | LRMR | Larimar Therapeutics, Inc. | 467.47M | -1.32% | 1,201,819 | - |
| 474 | ANGO | AngioDynamics, Inc. | 466.84M | 0.63% | 273,083 | 313.73M |
| 475 | AURA | Aura Biosciences, Inc. | 465.73M | -3.20% | 296,009 | - |
| 476 | RGNX | REGENXBIO Inc. | 464.04M | -3.75% | 483,724 | 170.44M |
| 477 | CTNM | Contineum Therapeutics, Inc. | 463.71M | -4.17% | 94,236 | - |
| 478 | FLGT | Fulgent Genetics, Inc. | 462.38M | -1.60% | 363,210 | 322.67M |
| 479 | TRDA | Entrada Therapeutics, Inc. | 461.16M | -1.84% | 160,226 | 25.42M |
| 480 | MYGN | Myriad Genetics, Inc. | 452.38M | -5.71% | 1,201,513 | 824.50M |
| 481 | XOMA | XOMA Royalty Corporation | 451.49M | -3.76% | 65,247 | 52.15M |
| 482 | ASMB | Assembly Biosciences, Inc. | 450.98M | 0.46% | 78,968 | 72.30M |
| 483 | DNA | Ginkgo Bioworks Holdings, Inc. | 448.20M | -8.77% | 808,677 | 170.16M |
| 484 | LXEO | Lexeo Therapeutics, Inc. | 445.26M | -5.06% | 1,077,562 | - |
| 485 | PRLD | Prelude Therapeutics Incorporated | 442.43M | 2.09% | 716,569 | 12.14M |
| 486 | AVIR | Atea Pharmaceuticals, Inc. | 439.79M | -1.60% | 120,238 | - |
| 487 | AGL | agilon health, inc. | 436.77M | -7.06% | 369,569 | 5.93B |
| 488 | EPRX | Eupraxia Pharmaceuticals Inc. | 435.80M | 2.69% | 192,559 | - |
| 489 | BNTC | Benitec Biopharma Inc. | 435.04M | -2.01% | 115,673 | - |
| 490 | VTVT | vTv Therapeutics Inc. | 432.47M | -13.84% | 86,968 | 17.00K |
| 491 | CLYM | Climb Bio, Inc. | 430.87M | -3.01% | 456,182 | - |
| 492 | IVVD | Invivyd, Inc. | 427.03M | -5.63% | 1,451,795 | 53.43M |
| 493 | NGNE | Neurogene Inc. | 420.85M | -1.17% | 134,606 | 925.00K |
| 494 | EBS | Emergent BioSolutions Inc. | 417.80M | -2.41% | 260,810 | 742.90M |
| 495 | PRTC | PureTech Health plc | 413.57M | -0.50% | 9,740 | 6.39M |
| 496 | SRTA | Strata Critical Medical, Inc. | 411.49M | -4.80% | 618,813 | 197.14M |
| 497 | KIDS | OrthoPediatrics Corp. | 409.77M | -0.98% | 85,916 | 236.35M |
| 498 | NMRA | Neumora Therapeutics, Inc. | 407.39M | -3.46% | 1,186,865 | - |
| 499 | AUTL | Autolus Therapeutics plc | 407.20M | -4.38% | 1,294,437 | 75.39M |
| 500 | IPSC | Century Therapeutics, Inc. | 406.93M | -7.57% | 776,672 | 109.16M |